1. Joshi Shashank R

9789352705214

10.5005/jp/books/18084_17

1/e

2019

8

1. Joshi Clinic, Lilavati and Bhatia Hospital; Endocrine Society of India, Indian Academy of Diabetes, Association of Physicians of India (API) (2014–15), Mumbai, Maharashtra, India, Joshi Clinic, Lilavati Hospital, Sir HN, Reliance and Bhatia Hospitals, Mumbai, Maharashtra, India, Joshi Clinic, Apollo Sugar Clinic, Lilavati and Bhatia Hospitals, Mumbai, Maharashtra, India, Joshi Clinic, Apollo Sugar Clinic, Lilavati and Bhatia Hospital, Mumbai, Maharashtra, India; Research Society for the Study of Diabetes in India, 2011; Southeast Asia Region; Physicians of India, Endocrine Society of India, Hypertension Society of India;, Joshi Clinic, Lilavati and Bhatia Hospital, Mumbai, Maharashtra, India, Joshi Clinic, Lilavati Hospital, Apollo, Sugar Clinic and Bhatia Hospital, Mumbai, Maharashtra, India, Joshi Clinic, Lilavati Hospita; Apollo Sugar Clinic and Bhatia Hospital, Mumbai, Maharashtra, India; API–2015; PCOS Society; Indian Thyroid Society; JAPI; IAD & HIS, Grant Medical College and Sir JJ Group of Hospita

Diabetes, heart failure, type 2 diabetes mellitus, glycemia control, antidiabetic therapy, metformin, sodium-glucose cotransporter 2 inhibitor, dipeptidyl peptidase-4 inhibitor, glucagon-like peptide-1 receptor agonist, sulfonylureas, thiazolidinediones, insulin